Medifast
James V. Charlot is a Senior FP&A Analyst at Medifast, Inc., with previous experience as an Equity Derivatives Product Controller at Morgan Stanley, where responsibilities included P&L reporting and variance analysis for derivatives trading. Prior to that, as a Financial Analyst at Bartlett Tree Experts, James managed a substantial annual budget across numerous divisions and was involved in key financial reporting. Early career roles included internships in general ledger management, tax preparation, and accounting, alongside serving as a Financial Literacy Peer Leader at Western Connecticut State University, where James organized educational workshops. James holds a BBA in Finance and Financial Management Services and a BBA in Accounting and Business/Management from Western Connecticut State University, as well as an Associate degree in Insurance and Financial Services.
Medifast
5 followers
Medifast (NYSE: MED) is the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformation, One Healthy Habit at a Time®. Based on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independent OPTAVIA Coaches teach Clients to develop holistic healthy habits through products and clinically proven plans, the Habits of Health® Transformational System and comprehensive support from a community of like-minded people. In 2019, Medifast expanded the OPTAVIA movement globally, beginning with the Asia-Pacific region. Medifast is traded on the New York Stock Exchange and was named to Fortune's 100 Fastest-Growing Companies list in 2019 and Forbes' 100 Most Trustworthy Companies in America list in 2016 and 2017. For more information, visit www.MedifastInc.com or www.OPTAVIA.com.